Mouad Abdulrahim Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

Last publication 2024 Last refreshed 2026-05-16

unknown

3 h-index 3 pubs 24 cited

Biography and Research Information

OverviewAI-generated summary

Mouad Abdulrahim's research focuses on the molecular mechanisms underlying cancer, particularly acute myeloid leukemia. His recent work, published in 2024, investigates how pyrimidine depletion can enhance the effectiveness of combination therapies involving targeted treatments and immunotherapy in acute myeloid leukemia. Abdulrahim also has experience with clinical case reports, with publications in 2023 on corticosteroid-induced psychosis and in 2022 on the management of psychosis associated with Graves’ disease.

His scholarly work includes three publications with 21 total citations and an h-index of 3. Abdulrahim collaborates with researchers from institutions including the University of Arkansas for Medical Sciences and the University of Arkansas – Fort Smith. His recent activity indicates ongoing engagement in research.

Metrics

  • h-index: 3
  • Publications: 3
  • Citations: 24

Selected Publications

  • Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia (2024)
    5 citations DOI OpenAlex
  • Corticosteroid-Induced Psychosis: A Report of Three Cases (2023)
    8 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

34 Collaborators 13 Institutions 3 Countries

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics